Analystreport

Histogenics Corp (NASDAQ: HSGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com